2008: 2nd International Symposium: Progress on Personalizing Medicines

Thursday 25th September, 2008
Lecture Theatre, Clinical Sciences Building,
University Hospital Campus, Coventry

Scientific Board: V Arnason, Reykjavik, Iceland, Ethics; L Biron, Cambridge UK, International Health; Léonie Brown, Autonomy, Cambridge, Context Sensitive Searching; ND Carter, London, Genetics; WL Currie, Warwick, eHealth; Michelle Cuddigan, IBM; R Edwards, WHO Uppsala, Pharmacovigilance; G Guillermo-Garcia, Harvard, Boston, Endothelial Genomics; A Marsh, Warwick, Chemical Genomics; M Parton, NHS Health Technology Adoption, Manchester; A Shindler, London, Intellectual Property; I Scott, Ipswich, Medicine Risk and eHealth systems; DRJ Singer, Warwick, Clinical Pharmacology; J Zhang, Warwick, Molecular Endocrinology.

Symposium speakers at the Warwick Institute for Advanced Study

Speakers' workshop at the Warwick Institute for Advanced Study:

V Arnason, Reykjavik, L Biron, Cambridge, DRJ Singer &
WL Currie, Warwick.

Speakers' workshop at the Warwick Institute for Advanced Study:
L Biron, Cambridge, V Arnason, Reykjavik, WL Currie, Warwick,
and R Edwards, WHO, Uppsala

Scientific Programme

8.50 Welcome
Professor Margot Finn, Director, Institute of Advanced Study
University of Warwick

9.00 Keynote lecture jointly with Grand Round
From Genome to the Clinic:
Laying the Foundations for Personalised Medicine
Dr Alex Doney, Dundee
ABSTRACT

9.55 Presentation of Clinical Pharmacology Case Report Award

10.20 In the interests of the patient: how healthcare and the pharma
industry are converging for the benefits of patients
Michelle Cuddigan, IBM Global
ABSTRACT

10.40 Intuitive software approaches to improving patient safety
Léonie Brown, Autonomy, Cambridge, UK
ABSTRACT

11.00 Applying virtual clinics to reducing cardiovascular disease risk
Professor Donald Singer, Warwick Medical School
ABSTRACT

11.25 Progress on Personalising Medicines.
Managing the Risk
Dr Ian Scott, Ipswich
National Clinical Lead for Hospital Doctors
Connecting for Health
ABSTRACT

12.00 Personalising Medicine – Not just a pill
Margaret Parton, Chief Executive
NHS Technology Adoption Centre.
ABSTRACT
Chair: Richard Kennedy, Medical Director, University Hospital

12.30 Panel discussion
Chair: Professor Wendy Currie, Warwick Business School

14.00 Chemical genomics for targeted drug discovery
Andrew Marsh, Warwick
Chair: Professor Alison Rodger, Director of MOAC
University of Warwick
ABSTRACT

14.45 Rewarding genomic research in developing countries:
the prospects for a health impact fund.
Laura Biron, Cambridge, UK
ABSTRACT

16.00 Personalized Medicine? Ethical Questions and Challenges
Professor Vilhjalmur Arnason, Reykjavik, Iceland
ABSTRACT

16.45 Signal detection and role of CYP variability
in adverse drug reactions
Professor Ralph Edwards, Director, WHO Monitoring Centre
Uppsala, Sweden

Key themes